Session Details

U070 Simple Tricks and Practical Tips to Optimize the Surgical Experience for You and Your Patients

Sun, Mar 29, 8:00 AM - 9:00 AM
Mile High 2C
1 CME Available Focus Session Upcoming
View Map

DESCRIPTION

Hidradenitis Suppurativa (HS) is a devastating chronic condition with the lowest quality of life of any skin condition that disproportionately affects women and patients of low socio-economic status. Despite the recent expansion of biologic therapies, patients with moderate and severe HS with established sinus tracts and tunnels, need surgical intervention to manage their disease. This focus session will review and discuss the different in-office surgical treatments using liquid nitrogen, hair removal lasers, surgical instruments and Co2 lasers that should be a part of a dermatologist’s surgical skill set. We also plan to discuss post-op care and most common complications seen after these procedures.

LEARNING OBJECTIVES

1.

Apply specific tips to optimize the surgical experience and improve patient satisfaction.

2.

Manage and prevent common but challenging scenarios in dermatologic surgery and surgical complications.

DIRECTOR

Charlene Lam, MD, MPH, FAAD

Charlene Lam, MD, MPH, FAAD

SPEAKERS

Elizabeth M. Billingsley, MD, FAAD

Elizabeth M. Billingsley, MD, FAAD

Marc D. Brown, MD, FAAD

Marc D. Brown, MD, FAAD

Franki Lenae Lambert Smith, MD, FAAD

Franki Lenae Lambert Smith, MD, FAAD

Allison Therese Vidimos, MD, RPh, FAAD

Allison Therese Vidimos, MD, RPh, FAAD

DISCLOSURES

Elizabeth M. Billingsley, MD, FAAD

Inhibitor Therapeutics – Consultant (1099 relationship)(Fees); PellePharm, Inc. – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Sol Gel Technologies – Investigator(Grants/Research Funding);

Marc D. Brown, MD, FAAD

No financial relationships exist with ineligible companies.

Charlene Lam, MD, MPH, FAAD

No financial relationships exist with ineligible companies.

Franki Lenae Lambert Smith, MD, FAAD

No financial relationships exist with ineligible companies.

Allison Therese Vidimos, MD, RPh, FAAD

Castle Biosciences – Investigator(Grants/Research Funding); Inhibitor therapeutics – Advisory Board(No Compensation Received); Regeneron – Data Safety Monitoring Board(Fees); UpToDate, Inc – Other(Honoraria);